Medtronic Talent thoracic stent graft debuts
This article was originally published in The Gray Sheet
Executive Summary
Endovascular thoracic stent graft launches June 8 at the Society for Vascular Surgery annual meeting in San Diego following FDA approval, announced June 5. The device is indicated to treat aneurysms of the descending thoracic aorta. The firm simultaneously unveiled its Talent abdominal aortic stent graft, approved by FDA in April. Major competitors in both the thoracic and abdominal stent graft space are Cook Medical, which gained approval for its Zenith TX2 thoracic aortic aneurysm graft May 21, and W.L. Gore